11th Annual Spring to Life

Conference on Genitourinary and Gynecologic Cancers

Thursday, May 2, 2024 - Friday, May 3, 2024
Albany Capital Center, Albany, NY

Proudly Hosted by New York Oncology Hematology, PC

COMMUNITY-BASED CANCER CARE AFFILIATE:

Image

Event Information

Image
  • The conference will be Live In-Person and Online via a Live Broadcast

Registration Fees:
Per day:
$0 Fellows/Students
$0 NYOH, Albany Med, and US Oncology
$25 APP
$35 MD
$200 Industry

Cancellation Policy:
Cancellations and refunds will be processed based on the following:
Up to 30 days prior to the conference = 100%
29 - 15 days prior to the conference = 50%
14-7 days prior to the conference = 25%
6-0 days prior to the conference = 0%
If you would like to request a refund, please email [email protected]

If you would like to receive notifications about the conference, please provide the following information:

Registration/Contact Information

S2L | Registration HCP
(NOTE: NYOH, Albany Med, and US Oncology must use their organization email to receive comp’d registration)
FOR MD/DOs only: Would you like to be included in opportunities to participate in ancillary events such as Advisory Boards, organized during the conference series?
Please select the session(s) you are registering for:
Please select the session(s) you are registering for:
Please select the session(s) you are registering for:
Please select the session(s) you are registering for:

Note: promo codes are not applicable to Industry Registrations

I plan to attend:

THE LIVE STREAM LOGIN INSTRUCTIONS WILL BE SENT TO THE EMAIL YOU ENTERED TO REGISTER. YOU MUST BE REGISTERED TO RECEIVE THE LOGIN INSTRUCTIONS.
DETAILS FOR DAY 1: MAY 2, 2024 – GENITOURINARY CANCERS

EDUCATIONAL GOAL

Our program will bring together a world-renowned group of experts in the field of genitourinary oncology to present the latest clinical research data in this field. The target audience will be medical personnel who manage genitourinary cancers, including physicians, nurse practitioners, physician assistants, and chemotherapy nurses, but will also be open to nonprofessionals.

TARGET AUDIENCE

The target audience for this conference is medical oncologists, hematologists, pathologists, oncology nurses, fellows, residents, advanced practice providers, family practitioners, primary care practitioners, allied health professionals, and other providers interested in the care of patients with cancer.

LEARNING OBJECTIVES

After participating in this activity, learners will be better able to:

  1. Determine optimal surgical options for non-invasive and invasive urothelial cancers, renal cancers, and localized prostate cancer.
  2. Evaluate systemic therapy options, including new targeted therapies, for non-invasive and invasive urothelial cancers, renal cancers, prostate cancers, germ cell tumors, and testicular cancer.
  3. Understand current radiation therapy management of localized prostate cancer.

AGENDA

DOWNLOAD CURRENT AGENDA

CONFERENCE COURSE CHAIR

Image

Ira Zackon, MD
New York Oncology Hematology,
Immediate Past President
Hematologist/Medical Oncologist
NYOH Albany Medical Center
Clinical Assistant Professor
Albany Medical College
Albany, NY

SESSION CHAIR

Image

David R. Shaffer, MD
Medical Oncologist NYOH, retired
President Board of Directors, NYOH Community Cancer Foundation 
Albany, New York

FACULTY

Timothy Donahue, MD (MSKCC)
Darren Feldman, MD (MSKCC)
Ari Hakimi, MD (MSKCC)
Gopa Iyer, MD (MSKCC)
Justin Juliano, MD (NYOH)
Rahul Ravilla, MD (NYOH)
Susan Slovin, MD (MSKCC)
Karim Touijer, MD (MSKCC)
Martin Voss, MD (MSKCC)

The mission of Spring to Life™ is to reflect and transmit all that is evolving in the whole of the field of oncology.   The annual conference continues to bring together faculty speakers that reflect local, regional and national expertise in the field.  This collaboration of community-based oncologists with academic leaders highlights the impact of the research that advances our understanding and ultimately impacts the lives of our patients whom we serve.

Click on the links below to view the programs from years past.

2014 The Acute Leukemias - AML and ALL
2015 Aggresive B-Cell Non-Hodgkin Lymphomas
2016 Plasma Cell Diseases
2017 Myeloproliferative Neoplasms (MPNs)
2018 Incident Lymphoid Malignancies
2019 Harnessing the Power of our Immune System in Cancer Therapy
2020 Lung Cancer
2021 Leukemias
2022 Gastrointestinal Cancers
2023 Aggressive Lymphomas

Thank you to the collaborators, educational grant providers, sponsors and exhibitors, past and present, who have made this event possible:

  • AbbVie, Inc.
  • AbbVie Oncology
  • Adaptive Biotechnologies
  • ADC Therapeutics
  • Agios
  • Alexion Pharmaceuticals, Inc.
  • Amgen (Oncology and Hematology)
  • Amyloidosis Support Groups
  • Apellis Pharmaceuticals
  • Astellas Pharma US, Inc.
  • AstraZeneca US
  • Be The Match
  • BeiGene
  • Boehringer Ingelheim
  • Blueprint Medicines
  • Bristol-Myers Squibb
  • Bristol-Myers Squibb Oncology
  • Cancer Hope Network
  • Caris Life Sciences
  • Celgene Corporation
  • CLL Support Group of Albany
  • CRAAB
  • CTI BioPharma
  • Daiichi Sankyo, Inc.
  • Eisai Oncology, Inc.
  • Epizyme, Inc.
  • Exelixis, Inc.
  • Foundation Medicine
  • Genentech USA, Inc.
  • Genomic Health, Inc.
  • Genoptix, A NeoGenomics Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline
  • Global Blood Therapeutics, Inc.
  • Guardant Health, Inc.
  • Incyte Corporation
  • Ipsen
  • Janssen Biotech, Inc.
  • Janssen Pharmaceuticals, Inc
  • Jazz Pharmaceuticals plc
  • Karyopharm Therapeutics
  • Kite Pharma
  • Kyowa Kirin
  • Leukemia & Lymphoma Society
  • Lilly USA, LLC
  • Lung Cancer Research Foundation
  • Maddie’s Mark
  • Make-A-Wish Northeast New York
  • Med News Online
  • Melodies Center at the Children’s Hospital, Albany
    • Medical Center
  • Merck
  • Millennium Pharmaceuticals, Inc.
  • Morphosys US
  • NeoGenomics Laboratories, Inc
  • New York Oncology Hematology
  • Nick’s Fight to be Healed Foundation
  • Novartis
  • Novartis Hematology
  • Novartis Oncology Onyx Pharmaceuticals, Inc.
  • Oncopeptides
  • Otsuka America Pharmaceutical, Inc.
  • Pfizer
  • Pfizer Oncology
  • Pharmacyclics LLC, an AbbVie Company
  • Pharmacosmos Therapeutics
  • Prometheus
  • Rigel Pharmaceuticals
  • Sandoz BioPharmaceuticals
  • Sanofi-Genzyme & Regeneron
  • Seagen
  • Servier Pharmaceuticals
  • Shire
  • Spectrum Pharmaceuticals
  • Stemline Therapeutics
  • Susan G. Komen
  • Taiho
  • Takeda Hematology
  • Takeda Oncology
  • Teva Pharmaceutical Industries Ltd.
  • TG Therapeutics
  • Verastem, Inc.
CONTACT US

This Activity Is Planned By myMedEd, Inc.

Image
Educational Partners
ImageImage

Accredited Provider

Image